112 related articles for article (PubMed ID: 215232)
1. Plasminogen activator from cells transformed by an oncogenic virus: inhibitors of the activation reaction.
Danø K; Reich E
Biochim Biophys Acta; 1979 Jan; 566(1):138-51. PubMed ID: 215232
[TBL] [Abstract][Full Text] [Related]
2. Inhibition of a plasminogen activator from oncogenic virus-transformed mouse cells by rabbit antibodies against the enzyme.
Danø K; Nielsen LS; Møller V; Engelhart M
Biochim Biophys Acta; 1980 Jun; 630(1):146-51. PubMed ID: 6248125
[TBL] [Abstract][Full Text] [Related]
3. A direct, plasmin-independent assay for plasminogen activator.
Mussoni L; Lawrence D; Loskutoff DJ
Thromb Res; 1984 May; 34(3):241-54. PubMed ID: 6233750
[TBL] [Abstract][Full Text] [Related]
4. Expression of the catalytic activity of plasminogen activator under physiologic conditions.
Aggeler J; Risch J; Werb Z
Biochim Biophys Acta; 1981 Jun; 675(1):62-8. PubMed ID: 6455162
[TBL] [Abstract][Full Text] [Related]
5. The plasma inhibitors of plasminogen activator, studied by a zymographic technique.
Booth NA; Anderson JA; Bennett B
Thromb Res; 1985 May; 38(3):261-7. PubMed ID: 3161209
[TBL] [Abstract][Full Text] [Related]
6. Inhibition of plasminogen activation protects against ganglion cell loss in a mouse model of retinal damage.
Zhang X; Chaudhry A; Chintala SK
Mol Vis; 2003 Jun; 9():238-48. PubMed ID: 12813409
[TBL] [Abstract][Full Text] [Related]
7. Characterization of a macrophage-derived plasminogen-activator inhibitor. Similarities with placental urokinase inhibitor.
Chapman HA; Stone OL
Biochem J; 1985 Aug; 230(1):109-16. PubMed ID: 2932100
[TBL] [Abstract][Full Text] [Related]
8. Activation of pro-urokinase and plasminogen on human sarcoma cells: a proteolytic system with surface-bound reactants.
Stephens RW; Pöllänen J; Tapiovaara H; Leung KC; Sim PS; Salonen EM; Rønne E; Behrendt N; Danø K; Vaheri A
J Cell Biol; 1989 May; 108(5):1987-95. PubMed ID: 2523891
[TBL] [Abstract][Full Text] [Related]
9. The behavior of alpha2-plasmin inhibitor in fibrinolytic states.
Aoki N; Moroi M; Matsuda M; Tachiya K
J Clin Invest; 1977 Aug; 60(2):361-9. PubMed ID: 68962
[TBL] [Abstract][Full Text] [Related]
10. Sequence of formation of molecular forms of plasminogen and plasmin-inhibitor complexes in plasma activated by urokinase or tissue-type plasminogen activator.
Thorsen S; Müllertz S; Suenson E; Kok P
Biochem J; 1984 Oct; 223(1):179-87. PubMed ID: 6208894
[TBL] [Abstract][Full Text] [Related]
11. Kinetics of the reaction between urokinase and an inhibitor of fibrinolysis from placental tissue.
Christensen U; Holmberg L; Bladh B; Astedt B
Thromb Haemost; 1982 Aug; 48(1):24-6. PubMed ID: 6813991
[TBL] [Abstract][Full Text] [Related]
12. The irreversible inhibition of urokinase, kidney-cell plasminogen activator, plasmin and beta-trypsin by 1-(N-6-amino-n-hexyl)carbamoylimidazole.
Walker B; Elmore DT
Biochem J; 1984 Jul; 221(1):277-80. PubMed ID: 6235806
[TBL] [Abstract][Full Text] [Related]
13. Fibrinolysis in health and disease: severe abnormalities in systemic lupus erythematosus.
Glas-Greenwalt P; Kant KS; Allen C; Pollak VE
J Lab Clin Med; 1984 Dec; 104(6):962-76. PubMed ID: 6239000
[TBL] [Abstract][Full Text] [Related]
14. Interfering factors in the assay of plasminogen activators by the fibrin plate method. Occurrence of different inhibitors against tissue plasminogen activator and urokinase.
Wijngaards G
Thromb Haemost; 1979 May; 41(3):590-600. PubMed ID: 111368
[TBL] [Abstract][Full Text] [Related]
15. Inactivation of the plasminogen activator from HeLa cells by peptides of arginine chloromethyl ketone.
Coleman P; Kettner C; Shaw E
Biochim Biophys Acta; 1979 Jul; 569(1):41-51. PubMed ID: 111716
[TBL] [Abstract][Full Text] [Related]
16. The influence of the polyphenols of cider on plasmin and plasminogen activators.
Ogston D; Lea AG; Langhorne P; Wilson SB
Br J Haematol; 1985 Aug; 60(4):705-13. PubMed ID: 3161536
[TBL] [Abstract][Full Text] [Related]
17. Detection and partial characterization of a specific plasminogen activator inhibitor in human chondrocyte cultures.
Yamada H; Stephens RW; Nakagawa T; McNicol D
J Biochem; 1988 Dec; 104(6):960-7. PubMed ID: 3149640
[TBL] [Abstract][Full Text] [Related]
18. Identification of the human plasma protein which inhibits fibrinolysis associated with malignant cells.
Collen D; Billiau A; Edy J; De Somer P
Biochim Biophys Acta; 1977 Sep; 499(2):194-201. PubMed ID: 198009
[No Abstract] [Full Text] [Related]
19. Complementary modes of action of tissue-type plasminogen activator and pro-urokinase by which their synergistic effect on clot lysis may be explained.
Pannell R; Black J; Gurewich V
J Clin Invest; 1988 Mar; 81(3):853-9. PubMed ID: 2963831
[TBL] [Abstract][Full Text] [Related]
20. Urokinase regulates embryonic cardiac cushion cell migration without converting plasminogen.
Gorny KN; Brauer PR
Anat Rec; 1999 Nov; 256(3):269-78. PubMed ID: 10521785
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
